Zhibin Liao

机构：Chinese Academy of Sciences, Tongji Hospital, Shanghai Institute of Ceramics, University of Chinese Academy of Sciences, Huazhong University of Science and Technology, The University of Adelaide · ORCID：0000-0003-0305-2079

发表论文 67 篇 · 总被引 1787 次 · h-index 24

代表论文

• Integrinβ-1 in disorders and cancers: molecular mechanisms and therapeutic targets (2024 · Cell Communication and Signaling · 被引 85)
• MYC in liver cancer: mechanisms and targeted therapy opportunities (2023 · Oncogene · 被引 53)
• EZH2 in hepatocellular carcinoma: progression, immunity, and potential targeting therapies (2023 · Experimental Hematology and Oncology · 被引 53)
• ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner (2023 · Experimental Hematology and Oncology · 被引 50)
• ALKBH5-mediated m6A modification of lincRNA LINC02551 enhances the stability of DDX24 to promote hepatocellular carcinoma growth and metastasis (2022 · Cell Death and Disease · 被引 44)
• USF2-mediated upregulation of TXNRD1 contributes to hepatocellular carcinoma progression by activating Akt/mTOR signaling (2022 · Cell Death and Disease · 被引 35)